I2906 Size:Solid 10 mg Nafamostat mesilate produces concentration-dependent inhibition

Nafamostat mesilate produces concentration-dependent inhibition of the initial-phase transient component of biphasic ASIC3 currents with an IC50 value of approximately 2

Clin Pharmacol Ther

CUDC-907 was orally dosed to mice at 100 mg/kg or intravenously dosed at 50 mg/kg once per day in the xenograft tumor model of SU-DHL4 (DLBCL) and A549 (NSCLC)

InChi: InChI=1S/C9H10N4O2

4-dihydroquinoline-3-carboxamide

I2906 Size:Solid 10 mg Nafamostat mesilate produces concentration-dependent inhibitionI2906 showed antimycobacterial and cytotoxic activity against mycobacterium tuberculosis. IC50 Value: Target: AntibacterialUnder in vitro conditions, I2906 showed excellent antimycobacterial activities and low cytotoxicity. In a murine model infected with M. tuberculosis H37Rv, the reductions on bacterial loads of both lungs and spleen were statistically significant (p Product information CAS Number: 331963 29 2 Molecular Weight: 443. 58 Formula: